Hexarelin Research Guide
2mg · Research compound — not for human consumption
Research Overview
Hexarelin is a synthetic hexapeptide growth-hormone-releasing peptide (GHRP) that has been studied in preclinical models for its interaction with the growth-hormone-secretagogue receptor. It has been examined in rodent and other laboratory systems as a research compound. This material is intended for laboratory research only and is not intended for human consumption.
Structural & Class Overview
A synthetic hexapeptide of the GHRP family classified as an agonist of the growth-hormone-secretagogue receptor subtype 1a (GHS-R1a), part of the ghrelin-receptor system expressed in the pituitary, hypothalamus, and peripheral tissues. Research describes activity through direct pituitary action and indirect hypothalamic mechanisms.
General Research Interest
Research interest includes GHS-R1a binding and receptor mRNA modulation in preclinical models; growth-hormone-releasing activity in infant versus adult rodent systems; synergy with GHRH-receptor signaling; hypothalamic-pituitary regulation studies; and broader growth-hormone-axis biology.
Storage Considerations
Store the lyophilized research peptide cool and dark, and protect from light, heat, and moisture. Reconstituted material is generally handled under refrigeration for laboratory use. For research handling only; not for human use.
Testing & Quality Considerations
Quality considerations for research material include HPLC purity assessment, mass-spectrometry identity confirmation, and verification against a batch Certificate of Analysis (COA).
References
- GH-releasing activity of Hexarelin in infant and adult rats (PubMed)
- Hexarelin modulates expression of GHS-receptor type 1a mRNA (PubMed)
References are provided for scientific context. Linked sources are independent and not affiliated with iNGEN MD.
